Table 3 Health facility and Medication related variables of study participants on follow up of ART at selected public and private health facilities of Adama town, East shewa zone, oromia, Ethiopia, 2021
Variable | Case (n = 116) | Control (n = 231) |
|---|---|---|
Frequency (percentage) | Frequency (percentage) | |
Distance from Health facility | ||
< 10 km | 73(62.9%) | 156(67.5%) |
> 10 km | 43(37.1%) | 75(32.5%) |
Type of health facility | ||
Government | 80(69%) | 178(77.1%) |
Private | 36(31%) | 53(22.9%) |
Level of health facility | ||
Hospital | 64(55.2%) | 104(45%) |
Health center | 52(44.8%) | 127(55%) |
Baseline first line drug regimen used | ||
D4T + 3TC + NVP | 7 (3%) | 1(0.43%) |
D4 + 3TC + EFV | 8 (6.9%) | 1(0.43%) |
ZDV + 3TC + NVP | 8(6.9%) | 1(0.43%) |
ZDV + 3TC + EFV | 4(3.4%) | 22(0.87%) |
TDF + 3TC + EFV | 79(68.1%) | 191(82.7%) |
TDF + 3TC + NVP | 2(1.7%) | 2(0.87%) |
TDF + 3TC + DTG | 3(2.6%) | 3(1.3%) |
Efavirenz based | ||
Yes | 96(82.8%) | 184(79.7%) |
No | 20(17.2%) | 47(20.3%) |
Nevirapine based | ||
Yes | 15(6.5%) | 24(10.4%) |
No | 101(93.5%) | 207(89.6%) |
Adverse effect of drug | ||
Yes | 5(4.3%) | 22(9.5%) |
No | 111(95.7%) | 209(89.5%) |
Duration on ART in month | ||
< 24 months | 10(8.6%) | 36(15.6%) |
24ˍ48 months | 28(24.8%) | 73(31.6%) |
> 48 months | 78((67.2%) | 122(52.8%) |
History of drug substitution | ||
Yes | 84(72.4%) | 146(63.2%) |
No | 329(27.6%) | 85(26.8%) |
History of CPT use | ||
Yes | 89(76.7%) | 135(58.4%) |
No | 27(23.3%) | 96(42.6%) |
History of IPT use | ||
Yes | 75(64.7%) | 171(74%) |
No | 41(35.3%) | 60(26%) |
History of ART drug interruption | ||
Yes | 33(28.4%) | 33(14.3%) |
No | 83(72.6%) | 19(85.7%) |